[Corrections] Correction to Lancet Oncol 2018; 19: 257–66

O'Connor OA, Lue JK, Sawas A, et al. Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1–2 trial. Lancet Oncol 2018; 19: 257–66—The name of the last author of this Article should have been John Kuruvilla. This correction has been made to the online version as of Feb 28, 2018.

http://ift.tt/2t3OLyr